| Factor XIII: a coagulation factor with multiple plasmatic and cellular functions L Muszbek, Z Bereczky, Z Bagoly, I Komáromi, É Katona Physiological reviews 91 (3), 931-972, 2011 | 534 | 2011 |
| Factor XIII deficiency M Karimi, Z Bereczky, N Cohan, L Muszbek Seminars in thrombosis and hemostasis 35 (04), 426-438, 2009 | 253 | 2009 |
| The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis L Muszbek, Z Bagoly, Z Bereczky, E Katona Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2008 | 179 | 2008 |
| Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency É Ajzner, Á Schlammadinger, A Kerényi, Z Bereczky, É Katona, ... Blood, The Journal of the American Society of Hematology 113 (3), 723-725, 2009 | 87 | 2009 |
| Factor XIII Val34Leu variant protects against coronary artery disease Z Vokó, Z Bereczky, E Katona, R Ádány, L Muszbek Thrombosis and haemostasis 97 (03), 458-463, 2007 | 86 | 2007 |
| Fibrin stabilization (factor XIII), fibrin structure and thrombosis Z Bereczky, Ë Katona, L Muszbek Pathophysiology of haemostasis and thrombosis 33 (5-6), 430-437, 2003 | 81 | 2003 |
| Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game Z Bereczky, KB Kovács, L Muszbek Walter de Gruyter 48 (s1), S53-S66, 2010 | 70 | 2010 |
| Antithrombin deficiency and its laboratory diagnosis L Muszbek, Z Bereczky, B Kovács, I Komáromi Walter de Gruyter 48 (s1), S67-S78, 2010 | 61 | 2010 |
| Factor XIII and atherothrombotic diseases L Muszbek, Z Bereczky, Z Bagoly, AH Shemirani, E Katona Seminars in thrombosis and hemostasis 31 (01), 018-033, 2010 | 59 | 2010 |
| Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the … Z Bereczky, E Balogh, É Katona, Z Pocsai, I Czuriga, G Széles, L Kárpáti, ... Thrombosis research 120 (4), 567-573, 2007 | 54 | 2007 |
| Platelet count and mean volume in acute stroke: a systematic review and meta-analysis F Sadeghi, S Kovács, KS Zsóri, Z Csiki, Z Bereczky, AH Shemirani Platelets 31 (6), 731-739, 2020 | 49 | 2020 |
| Interaction between homocysteine and lipoprotein (a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study E Balogh, Z Bereczky, É Katona, Z Kőszegi, I Édes, L Muszbek, I Czuriga Thrombosis research 129 (2), 133-138, 2012 | 46 | 2012 |
| Trombophilic screening for nonarteritic anterior ischemic optic neuropathy V Nagy, Z Steiber, L Takacs, G Vereb, A Berta, Z Bereczky, G Pfliegler Graefe's Archive for Clinical and Experimental Ophthalmology 244, 3-8, 2006 | 46 | 2006 |
| Elevated factor XIII level and the risk of myocardial infarction in women Z Bereczky, E Balogh, E Katona, I Czuriga, I Edes, L Muszbek Haematologica 92 (2), 287-288, 2007 | 44 | 2007 |
| Founder effect is responsible for the p. Leu131Phe heparin‐binding‐site antithrombin mutation common in Hungary: phenotype analysis in a large cohort R Gindele, Z Oláh, P Ilonczai, M Speker, Á Udvari, A Selmeczi, G Pfliegler, ... Journal of Thrombosis and Haemostasis 14 (4), 704-715, 2016 | 43 | 2016 |
| Factor XIII and venous thromboembolism Z Bereczky, L Muszbek Seminars in thrombosis and hemostasis 37 (03), 305-314, 2011 | 43 | 2011 |
| Synthesis and anticoagulant activity of bioisosteric sulfonic‐acid analogues of the antithrombin‐binding pentasaccharide domain of heparin M Herczeg, L Lázár, Z Bereczky, KE Kövér, I Timári, J Kappelmayer, ... Chemistry–A European Journal 18 (34), 10643-10652, 2012 | 37 | 2012 |
| New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals EG Kovács, É Katona, Z Bereczky, N Homoródi, L Balogh, E Tóth, ... Thrombosis Research 131 (4), 320-324, 2013 | 36 | 2013 |
| Characteristics of platelet count and size and diagnostic accuracy of mean platelet volume in patients with venous thromboembolism. A systematic review and meta-analysis S Kovács, Z Csiki, KS Zsóri, Z Bereczky, AH Shemirani Platelets 30 (2), 139-147, 2019 | 32 | 2019 |
| The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency B Kovács, Z Bereczky, Z Oláh, R Gindele, A Kerényi, A Selmeczi, Z Boda, ... American journal of clinical pathology 140 (5), 675-679, 2013 | 31 | 2013 |
